ATE256678T1 - 4-(2-pyridyl)piperazine als agonisten des 5ht7 rezeptors - Google Patents

4-(2-pyridyl)piperazine als agonisten des 5ht7 rezeptors

Info

Publication number: ATE256678T1
Authority: AT; Austria
Prior art keywords: agonist; piperazine; pyridyl; receptor; compounds
Prior art date: 2001-05-02

Application number

AT02252903T

Other languages

English (en)

Inventor

Vinod Dipak Parikh

Willard Mckowan Welch Jr

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-02

Filing date

2002-04-24

Publication date

2004-01-15

2002-04-24 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-01-15 Application granted granted Critical

2004-01-15 Publication of ATE256678T1 publication Critical patent/ATE256678T1/de

Links

108091005436 5-HT7 receptors Proteins 0.000 title 1
239000000556 agonist Substances 0.000 title 1
GZRKXKUVVPSREJ-UHFFFAOYSA-N pyridinylpiperazine Chemical compound C1CNCCN1C1=CC=CC=N1 GZRKXKUVVPSREJ-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
210000003169 central nervous system Anatomy 0.000 abstract 1
239000004031 partial agonist Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Anesthesiology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Nutrition Science (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)

AT02252903T 2001-05-02 2002-04-24 4-(2-pyridyl)piperazine als agonisten des 5ht7 rezeptors ATE256678T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28817801P	2001-05-02	2001-05-02
US28946601P	2001-05-08	2001-05-08

Publications (1)

Publication Number	Publication Date
ATE256678T1 true ATE256678T1 (de)	2004-01-15

Family

ID=26964875

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02252903T ATE256678T1 (de)	2001-05-02	2002-04-24	4-(2-pyridyl)piperazine als agonisten des 5ht7 rezeptors

Country Status (12)

Country	Link
US (2)	US20030008880A1 (de)
EP (1)	EP1254905B1 (de)
JP (1)	JP2003012648A (de)
AT (1)	ATE256678T1 (de)
BR (1)	BR0201569A (de)
CA (1)	CA2384344A1 (de)
DE (1)	DE60200135T2 (de)
DK (1)	DK1254905T3 (de)
ES (1)	ES2210218T3 (de)
MX (1)	MXPA02004409A (de)
PT (1)	PT1254905E (de)
TR (1)	TR200400027T4 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005035753A1 (ja)	2003-10-10	2005-04-21	Chugai Seiyaku Kabushiki Kaisha	機能蛋白質を代替する二重特異性抗体
AU2003271186A1 (en)	2003-10-14	2005-04-27	Chugai Seiyaku Kabushiki Kaisha	Double specific antibodies substituting for functional protein
US20050215551A1 (en) *	2004-03-25	2005-09-29	Solvay Pharmaceuticals B.V.	1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
AR049478A1 (es) *	2004-03-25	2006-08-09	Solvay Pharm Bv	Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
AR048112A1 (es) *	2004-03-25	2006-03-29	Solvay Pharm Bv	Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
US20060013874A1 (en) *	2004-07-15	2006-01-19	Solvay Pharmaceuticals B.V.	Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one
TW200914020A (en) *	2007-08-28	2009-04-01	Lilly Co Eli	Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists
EP2201002B1 (de)	2007-10-12	2012-03-07	Eli Lilly And Company	5-ht7-rezeptorantagonisten
EP2149373A1 (de) *	2008-08-01	2010-02-03	Laboratorios Del. Dr. Esteve, S.A.	5HT7-Rezeptorliganden und Zusammensetzungen damit
BR112016027096B1 (pt) *	2014-05-19	2023-04-11	Northeastern University	Composições farmacêuticas e compostos de receptores-alvo de serotonina e seus usos
DE102018120011B4 (de)	2018-08-16	2022-06-15	Trumpf Laser Und Systemtechnik Gmbh	Schweißverfahren zum Verbinden eines transparenten, aluminiumoxidhaltigen ersten Substrats mit einem opaken zweiten Substrat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9612885D0 (en) *	1996-06-20	1996-08-21	Smithkline Beecham Plc	Novel compounds
FR2761067B1 (fr) *	1997-03-20	1999-04-23	Synthelabo	Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique
GB9710523D0 (en) *	1997-05-23	1997-07-16	Smithkline Beecham Plc	Novel compounds

2002
- 2002-02-13 US US10/075,910 patent/US20030008880A1/en not_active Abandoned
- 2002-04-19 JP JP2002117420A patent/JP2003012648A/ja active Pending
- 2002-04-24 PT PT02252903T patent/PT1254905E/pt unknown
- 2002-04-24 DK DK02252903T patent/DK1254905T3/da active
- 2002-04-24 TR TR2004/00027T patent/TR200400027T4/xx unknown
- 2002-04-24 AT AT02252903T patent/ATE256678T1/de not_active IP Right Cessation
- 2002-04-24 ES ES02252903T patent/ES2210218T3/es not_active Expired - Lifetime
- 2002-04-24 DE DE60200135T patent/DE60200135T2/de not_active Expired - Fee Related
- 2002-04-24 EP EP02252903A patent/EP1254905B1/de not_active Expired - Lifetime
- 2002-04-30 MX MXPA02004409A patent/MXPA02004409A/es active IP Right Grant
- 2002-04-30 CA CA002384344A patent/CA2384344A1/en not_active Abandoned
- 2002-05-02 BR BR0201569-2A patent/BR0201569A/pt not_active IP Right Cessation
2003
- 2003-07-10 US US10/617,967 patent/US7009051B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE60200135D1 (de)	2004-01-29
CA2384344A1 (en)	2002-11-02
PT1254905E (pt)	2004-03-31
US7009051B2 (en)	2006-03-07
DE60200135T2 (de)	2004-06-03
BR0201569A (pt)	2003-06-10
ES2210218T3 (es)	2004-07-01
US20030008880A1 (en)	2003-01-09
TR200400027T4 (tr)	2004-03-22
MXPA02004409A (es)	2002-11-14
EP1254905A1 (de)	2002-11-06
DK1254905T3 (da)	2004-03-29
EP1254905B1 (de)	2003-12-17
US20040014769A1 (en)	2004-01-22
JP2003012648A (ja)	2003-01-15

Similar Documents

Publication	Publication Date	Title
DK0675886T3 (da)	2000-09-18	Aminomethylensubstituerede ikke-aromatiske heterocykler og deres anvendelse som substance P-antagonister
ES2194960T3 (es)	2003-12-01	N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
DE69903992D1 (de)	2003-01-02	Heterocyclische Carboxamide
CY1105233T1 (el)	2010-03-03	Παραγωγα κατιοντος 1,2,4 - θειαδιαζολιου ως ρυθμιστες υποδοχεα μελανοκορτινης
EA200301073A1 (ru)	2004-02-26	N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
ATE483706T1 (de)	2010-10-15	Weitere heteropolycyclische verbindungen und deren verwendung als antagonisten des metabotropen glutamatrezeptors
DE602006007556D1 (de)	2009-08-13	Heteroarylsulfonylstilbene als 5-ht2a-antagonisten
SE0400043D0 (sv)	2004-01-12	New compounds
ATE256678T1 (de)	2004-01-15	4-(2-pyridyl)piperazine als agonisten des 5ht7 rezeptors
ATE305787T1 (de)	2005-10-15	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
DE602004005016D1 (de)	2007-04-12	Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
ATE240953T1 (de)	2003-06-15	Carbazolcarboxamide als 5-ht1f agonisten
ATE406894T1 (de)	2008-09-15	4-(2-phenylsulfanyl-phenyl)-piperidin-derivate als serotonin-wiederaufnahme-hemmer
ES2166046T3 (es)	2002-04-01	Derivados de arilacrilamida como agonistas o antagonistas de 5ht1.
ATE498600T1 (de)	2011-03-15	Inden derivate als pharmazeutika
DE60108626D1 (de)	2005-03-03	Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer
CY1108837T1 (el)	2014-07-02	ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
ATE392896T1 (de)	2008-05-15	4-(2-phenyloxyphenyl)-piperidin- oder -1,2,3,6- tetrahydropyridin-derivate als serotonin- wiederaufnahme-hemmer
DE69814563D1 (de)	2003-06-18	Pyrrolo-(3,2-b)pyridine und ihre Verwendung als 5-HT1F Agonisten
EA200501579A1 (ru)	2006-04-28	Производные 4-(2-фенилсульфанилфенил)-1,2,3,6-тетрагидропиридина в качестве ингибиторов повторного поглощения серотонина
ATE383343T1 (de)	2008-01-15	Imidazolderivate verwendbar als histamin h3 rezeptorliganden
ATE359269T1 (de)	2007-05-15	4-arylsulphonylpiperidin-derivate als 5-ht2a - rezeptor antagonisten
NO20004075L (no)	2000-08-15	Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister
DE69827706D1 (de)	2004-12-30	5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
EA200501577A1 (ru)	2006-04-28	Производные 4-(2-фенилсульфанилфенил)пиперидина в качестве ингибиторов повторного поглощения серотонина

Legal Events

Date

Code

Title

Description

2004-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1254905

Country of ref document: EP

2008-01-15

REN

Ceased due to non-payment of the annual fee